## PSKY: Paramount Skydance Corporation - XLC: Communication Services

### Executive Summary

No thesis match: MRS_20 -9.1% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($11.35)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Warner Bros. Discovery Officially Rejects Paramountâ€™s Revised Offer, Stands by Netflix Deal**
- Source: The Hollywood Reporter | 20260107T120414 | Somewhat-Bearish | Relevance: 98%
- Warner Bros. Discovery has officially rejected Paramount's revised tender offer, despite the increased termination fee and Larry Ellison's personal backstop. The WBD board cited insufficient value, lack of certainty, and significant risks associated with what they termed the "largest LBO in history" compared to the conventional structure of the Netflix merger. WBD maintains its commitment to the Netflix deal, highlighting concerns over Paramount's litigious history and the perceived inadequacy of their offer.

**2. Netflix stock (NFLX) holds steady after hours as CFRA downgrade spotlights Warner deal risk**
- Source: ts2.tech | 20260106T080840 | Neutral | Relevance: 64%
- CFRA downgraded Netflix (NFLX) to Hold from Buy and lowered its price target to $100, citing risks associated with Netflix's pursuit of Warner Bros. Discovery. This downgrade puts the spotlight on potential challenges like regulatory review, financing costs, and the impact on Netflix's balance sheet. Investors are awaiting Netflix's Q4 results on January 20th for clarity on deal financing and their 2026 outlook.

**3. Netflix Supports Warner Bros. Discovery Board's Commitment to Merger Agreement**
- Source: Morningstar | 20260107T121233 | Bearish | Relevance: 61%
- Netflix has reiterated its support for the Warner Bros. Discovery (WBD) Board of Directors' commitment to their merger agreement, following a comprehensive review. The WBD Board reaffirmed that the Netflix transaction, valued at approximately $82.7 billion, is in the best interest of its stockholders, and recommended rejecting a revised offer from Paramount Skydance Corporation. Netflix emphasizes that this merger will combine complementary strengths to deliver greater value to stockholders, consumers, and the entertainment industry.

**4. Piper Sandler upgrades Colgate-Palmolive stock rating to Overweight**
- Source: Investing.com India | 20260107T105432 | Somewhat-Bullish | Relevance: 61%
- Piper Sandler upgraded Colgate-Palmolive (NYSE:CL) from Neutral to Overweight, raising its price target to $88.00 from $82.00, citing expectations for accelerated growth in 2026, particularly in emerging markets. The firm believes current stock pressures are priced in and highlighted the company's attractive geographic exposure and strong gross profit margin. This upgrade comes amidst varied analyst opinions, with RBC Capital also upgrading the stock, while Argus downgraded it due to margin pressures.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Freedom Capital | $14 | $0 | 0% |
| 2025-12-09 | Morgan Stanley | $12 | $10 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Freedom Capital | init | Hold |
| 2025-12-09 | Morgan Stanley | main | Underweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Lingotto Investment : 8.8% (+100.0%)
- Vanguard Group Inc: 3.4% (+100.0%)
- State Street Corpora: 2.6% (+100.0%)
- Blackrock Inc.: 1.6% (+100.0%)
- Kohlberg Kravis Robe: 1.5% (+100.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-6.9% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 11.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.84 indicates undervaluation relative to growth. Forward P/E 11.8x attractive for 58% earnings growth. Analyst sentiment positive (1 raises, avg +20%, $15 target (+19%)). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.6B |
| Beta | 1.19 |
| 52W Range | $9.95 - $20.86 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.84 |
| Forward P/E | 11.8 |
| Current P/E | 18.7 |
| YoY Growth | 58.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -2.3% to -9.1% (-6.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.1pp (needs >4.0% for momentum thesis). AM_20 at -8.3% indicates price below own 20MA trend. Underperforming sector by 8.3pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.14% (CS: 1) | Weak |
| RSI_14 | 30.9 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 0.916x | Below |
| vs SMA50 | 0.843x | Below |
| vs SMA200 | 0.890x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $12.37
- **Stop Loss:** $11.35 (8.2% risk)
- **Target:** $13.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 490
- **Position Value:** $6,061.30
- **Portfolio %:** 6.06%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $-0.12 | -129.6% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*